Study to Assess Platelet Dysfunction With Verify Now Assay

Completed

• Conditions: Platelet Aggregation Defects

• Registration Number: NCT01167218
• Lead Sponsor: NYU Langone Health

Brief Summary

The purpose of this study is to conduct a Verify now assay to detect platelet aggregation defects in patients with Myelodysplastic syndrome(MDS), immune thrombocytopenia purpura (ITP) and myeloproliferative disorders (MPD).

Detailed Description

Verify Now is a rapid, simple, point-of service assay to measure platelet aggregation. The verify now assay is designed to assess platelet function based on the ability of activated platelets to bind fibrinogen. It is hoped that this study will detect the subtle platelet functional abnormalities in patients with hematological disorders.

Study Timeline

• Study Start: 2009-12
• Study First Submitted: 2010-07-19
• Study First Submitted QC: 2010-07-21
• Study First Posted: 2010-07-22
• Primary Completion: 2012-02
• Study Completion: 2012-02
• Status Verified: 2019-02
• Last Update Submitted: 2019-02-04
• Last Update Posted: 2019-02-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 79

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
platelet aggregation defects	one year	to assess platelet aggregation defects

Trial Locations

Locations (1)

Winthrop University Hospital Oncology/Hematology Division; 🇺🇸 Mineola, New York, United States